In the USA market, Losartan Potassium prices followed a downward trajectory throughout the month of October 2022 on the back of soft demand dynamics in the domestic market. However, surging interest rates and deteriorating economic fundamentals threaten the market fundamentals, impacting the price trend of APIs in the United States.

As of 28th October 2022, the Losartan Potassium price in the USA is settled at around USD 81200/MT, measuring a decline of 1% month-on-month basis. Squeezed purchasing activities from domestic buyers amidst bearish demand from the pharmaceutical and healthcare sector have resulted in the Losartan Potassium price drop in the US market. On the other side, domestic merchants have sufficient availability to cater to domestic demand. As a result, North American markets are facing a growing glut of Losartan Potassium inventories. In order to increase the inquiries from the downstream sector and to clear their existing stockpiles, domestic merchants gradually reduced their quotations.

According to the most recent industry conditions analysis by the NABE (National Association for Business Economics) on 24th October, the economy of the USA continues to slow down and is likely already in recession or may soon be in recession. Moreover, rising concerns about the economy and fear of recession impact the price of Losartan Potassium as consumer spending from the domestic market drop. Furthermore, the rising inflation and protracted port congestion continue to stymie the market dynamics of the US.

However, the demand for Losartan Potassium may shift the balance in the upcoming month, which may prompt the market participants to increase Losartan Potassium prices in the USA.